2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)
Public ClinicalTrials.gov record NCT02916056. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open Label Extension Study for Continued Safety and Efficacy Evaluation of Azeliragon in Patients With Mild Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label extension study in patients with mild Alzheimer's disease who have completed participation in the azeliragon Phase 3 (STEADFAST) trial. Patients will receive azeliragon 5 mg/day for up to 2 years.
Study identification
- NCT ID
- NCT02916056
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 297 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- May 31, 2018
- Completion
- May 31, 2018
- Last update posted
- May 31, 2021
2016 – 2018
United States locations
- U.S. sites
- 65
- U.S. states
- 24
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85004 | — |
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Tucson | Arizona | 85724 | — |
| Not listed | Bellflower | California | 90706 | — |
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Fullerton | California | 92835 | — |
| Not listed | Glendale | California | 91206 | — |
| Not listed | Imperial | California | 92251 | — |
| Not listed | Irvine | California | 92614 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Long Beach | California | 90806 | — |
| Not listed | Riverside | California | 92506 | — |
| Not listed | San Bernardino | California | 92408 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Atlantis | Florida | 33462 | — |
| Not listed | Delray Beach | Florida | 33445 | — |
| Not listed | Hallandale | Florida | 33009 | — |
| Not listed | Hialeah | Florida | 33016 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Lake Worth | Florida | 33449 | — |
| Not listed | Miami | Florida | 33122 | — |
| Not listed | Miami | Florida | 33137 | — |
| Not listed | Miami Beach | Florida | 33140 | — |
| Not listed | Miami Lakes | Florida | 33014 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Sarasota | Florida | 34243 | — |
| Not listed | Sunrise | Florida | 33351 | — |
| Not listed | The Villages | Florida | 32162 | — |
| Not listed | Columbus | Georgia | 31909 | — |
| Not listed | Chicago | Illinois | 60640 | — |
| Not listed | Fairway | Kansas | 66205 | — |
| Not listed | Lexington | Kentucky | 40504 | — |
| Not listed | Baltimore | Maryland | 21208 | — |
| Not listed | Newton | Massachusetts | 02459 | — |
| Not listed | Plymouth | Massachusetts | 02360 | — |
| Not listed | Quincy | Massachusetts | 02169 | — |
| Not listed | Hattiesburg | Mississippi | 39401 | — |
| Not listed | Creve Coeur | Missouri | 63141 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Princeton | New Jersey | 08540 | — |
| Not listed | Albuquerque | New Mexico | 87109 | — |
| Not listed | Albany | New York | 12208 | — |
| Not listed | Lake Success | New York | 11042 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Staten Island | New York | 10312 | — |
| Not listed | Charlotte | North Carolina | 28270 | — |
| Not listed | Raleigh | North Carolina | 27607 | — |
| Not listed | Wilmington | North Carolina | 28401 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Shaker Heights | Ohio | 44122 | — |
| Not listed | Oklahoma City | Oklahoma | 73103 | — |
| Not listed | Oklahoma City | Oklahoma | 73118 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Portland | Oregon | 97225 | — |
| Not listed | Plains | Pennsylvania | 18705 | — |
| Not listed | East Providence | Rhode Island | 02914 | — |
| Not listed | East Providence | Rhode Island | 02916 | — |
| Not listed | Cordova | Tennessee | 38018 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | San Antonio | Texas | 78232 | — |
| Not listed | Wichita Falls | Texas | 76309 | — |
| Not listed | Murray | Utah | 84123 | — |
| Not listed | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02916056, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2021 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02916056 live on ClinicalTrials.gov.